Organogenesis specializes in advanced wound care and regenerative medicine, offering a range of innovative products designed to enhance the healing process. Their product lineup includes PuraPly, Apligraf, and Dermagraft, which utilize the body's natural healing capabilities by creating a conducive environment for tissue regeneration. These products are engineered to maintain moisture, regulate temperature, and protect wounds from infection, thereby facilitating the body's inherent ability to repair itself. The company emphasizes the importance of a hydrated microenvironment and the removal of necrotic tissue to promote effective healing, particularly for chronic and non-healing wounds.

In addition to their advanced wound care solutions, Organogenesis provides comprehensive support for healthcare providers through their Organogenesis Physician Solutions program. This initiative streamlines the delivery of wound care products directly to patients, enhancing compliance and improving clinical outcomes. The program includes tools for billing management, order tracking, and real-time analytics, allowing healthcare professionals to focus more on patient care. By integrating advanced regenerative technologies with robust support services, Organogenesis aims to elevate the standard of care in wound management and surgical applications.

United States

Organogenesis™ is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. 

Organogenesis

Company Details